ProCE Banner Activity

Frequently Asked Questions: Precision Medicine in Gynecologic Cancers

Clinical Thought

In this commentary, David Scott Miller, MD, FACOG, FACS; Domenica Lorusso, MD, PhD; and Hye Sook Chon, MD, address some of the most pressing questions on the management of endometrial, cervical, and ovarian cancers.

Released: June 30, 2023

Share

Faculty

Hye Sook Chon

Hye Sook Chon, MD

Associate Member
Clinical Trial Medical Director
Department of Gynecologic Oncology
Moffitt Cancer Center
Tampa, Florida

Domenica Lorusso

Domenica Lorusso, MD, PhD, Prof

Full Professor of Obstetrics and Gynecology
Humanitas University
Head of Gynecology Oncology Medical Unit
Humanitas Hospital San Pio X
Milan, Italy

David Scott Miller

David Scott Miller, MD, FACOG, FACS

Medical Director of Gynecologic Oncology
Chair, Cancer Committee
Parkland Health & Hospital System
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Direct and Dallas Foundation Chair in Gynecologic Oncology
Professor of Obstetrics and Gynecology
University of Texas Southwestern Medical Center
Dallas, Texas

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca, Eisai, GSK, Karyopharm Therapeutics, Merck Sharp & Dohme Corp.

AstraZeneca

Eisai

GSK

Karyopharm Therapeutics

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Hye Sook Chon, MD

Associate Member
Clinical Trial Medical Director
Department of Gynecologic Oncology
Moffitt Cancer Center
Tampa, Florida

Hye Sook Chon, MD, has no relevant financial relationships to disclose.

Domenica Lorusso, MD, PhD, Prof

Full Professor of Obstetrics and Gynecology
Humanitas University
Head of Gynecology Oncology Medical Unit
Humanitas Hospital San Pio X
Milan, Italy

Domenica Lorusso, MD, PhD: consultant/advisor/speaker: AstraZeneca, Clovis, Genmab, GlaxoSmithKline, Immunogen, Merck Sharp and Dohme.

David Scott Miller, MD, FACOG, FACS

Medical Director of Gynecologic Oncology
Chair, Cancer Committee
Parkland Health & Hospital System
Amy and Vernon E. Faulconer Distinguished Chair in Medical Science
Direct and Dallas Foundation Chair in Gynecologic Oncology
Professor of Obstetrics and Gynecology
University of Texas Southwestern Medical Center
Dallas, Texas

David Scott Miller, MD, FACOG, FACS: consultant/advisor/speaker: Agenus, AstraZeneca, Asymmetric, Eisai, Eisai Europe Limited, EMD Serono, GlaxoSmithKline, Immunogen, Incyte, iTeos Belgium SA, Karyopharm, Merck Sharp & Dohme, Myriad, Novartis, Novocure, Seagen, Tarveda Therapeutics; researcher (paid to institution): Advaxis, Advenchen, Aeterna Zentaris, Agenus, Akesobio, Aprea AB, AstraZeneca, Immunogen, Incyte, Janssen, Karyopharm, Mateon, Merck Sharp & Dohme, Millenium, NVision, Novartis, Pfizer, Regeneron, Syros, Tesaro, Tracon, US Biotest, Xenetic; researcher: EMD Serono Research & Development, Leap.